The DOI matches its Crossref record; 216 of the 219 references it cites were found in a registry or an index.
Pathogenesis of alcohol‐induced liver disease: Classical concepts and recent advances
Open accessAbstract
Alcoholic liver disease (ALD) is a primary consequence of heavy and prolonged drinking. ALD contributes to the bulk of liver disease burden worldwide. Progression of ALD is a multifactorial and multistep process that includes many genetic and environmental risk factors. The molecular pathogenesis of ALD involves alcohol metabolism and secondary mechanisms such as oxidative stress, endotoxin, cytokines and immune regulators. The histopathological manifestation of ALD occurs as an outcome of complex but controlled interactions between hepatic cell types. Hepatic stellate cells (HSCs) are the key drivers of fibrogenesis, but transformation of hepatocytes to myofibroblastoids also implicate parenchymal cells as playing an active role in hepatic fibrogenesis. Recent discoveries indicate that lipogenesis during the early stages of ALD is a risk for advancement to cirrhosis. Other recently identified novel molecules and physiological/cell signaling pathways include fibrinolysis, osteopontin, transforming growth factor‐β‐SMAD and hedgehog signaling, and involvement of novel cytokines in hepatic fibrogenesis. The observation that ALD and non‐alcoholic steatohepatitis share common pathways and genetic polymorphisms suggests operation of parallel pathogenic mechanisms. Future research involving genomics, epigenomics, deep sequencing and non‐coding regulatory elements holds promise to identify novel diagnostic and therapeutic targets for ALD. There is also a need for adequate animal models to study pathogenic mechanisms at the molecular level and targeted therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonoxidative pathway-derived metabolites, including PEth and FAEE, are also known to cause alcohol toxicity, but the mechanisms have not yet been determined [31,43].”
From Pathophysiological Aspects of Alcohol Metabolism in the Liver (2021) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2004) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095857 · Cited by 3,565
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.
MATTEONI, C., YOUNOSSI, Z., GRAMLICH, T., BOPARAI, N., LIU, Y., & MCCULLOUGH, A. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70506-8 · Cited by 3,345
Mechanisms of Hepatic Fibrogenesis
Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,687
Tanaka, Y., Nishida, N., Sugiyama, M., Kurosaki, M., Matsuura, K., Sakamoto, N., Nakagawa, M., Korenaga, M., Hino, K., Hige, S., et al. (2009) · Nature Genetics · doi:10.1038/ng.449 · Cited by 2,141
IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
Study, F. T. H. C., Suppiah, V., Moldovan, M. V., Ahlenstiel, G., Berg, T., Weltman, M., Abate, M. L., Bassendine, M. F., Spengler, U., Dore, G. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.447 · Cited by 1,829
Medzhitov, R. M., & Janeway, C. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008033430506 · Cited by 1,827
Eta-1 (Osteopontin): An Early Component of Type-1 (Cell-Mediated) Immunity
Ashkar, S., Weber, G. F., Panoutsakopoulou, V., Sanchirico, M. E., Jansson, M., Zawaideh, S., Rittling, S. R., Denhardt, D. T., Glimcher, M. J., & Cantor, H. (2000) · Science · doi:10.1126/science.287.5454.860 · Cited by 1,125
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
A meta-analysis of alcohol consumption and the risk of 15 diseases
Corrao, G. (2004) · Preventive Medicine · doi:10.1016/j.ypmed.2003.11.027 · Cited by 1,077
Research works printed but not linked: 12
- NAS, 2006, Towards Safer Drinking Cultures, National Alcohol Strategy 2006–2009
- Chikritzh T, 2003, Patterns of Alcohol Use and Related Harms for Australian States and Territories
- Haber PS, 1999, Clinical outcomes of liver transplantation for alcoholic liver disease (abst 198), J. Gastroenterol. Hepatol., 14, A130
- Chikritzhs T, 2000, National Alcohol Indicators Project
- Chikritzhs T, 2007, Bulletin 11: Trends in Alcohol‐Attributable Deaths Among Indigenous Australians, 1998–2004
- Younossi ZM, 1998, Clinics in Liver Disease, 661
- Seth D, 2006, Identification of Novel Therapeutic Targets for Alcoholic Liver Disease, 60A
- 10.1517/17425255.3.4.519 · DOI
- Seth D, 2006, Osteopontin: An Early Marker for Alcoholic Liver Injury?, 89A
- 10.1111/j.1530-0277.1998.tb03645.x · DOI
- 10.1002/hep.1840360610 · DOI
- 10.1111/j.1572-0241.2000.02030.x · DOI
Cited by
Sorted by citations
Pathophysiological Aspects of Alcohol Metabolism in the Liver
Hyun, J., Han, J., Lee, C., Yoon, M., & Jung, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115717 · Cited by 324
Alcoholic disease: Liver and beyond
Rocco, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14652 · Cited by 260
Marshall, S. A., McClain, J. A., Kelso, M. L., Hopkins, D. M., Pauly, J. R., & Nixon, K. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.12.016 · Cited by 254
Baicalin and the liver-gut system: Pharmacological bases explaining its therapeutic effects
Hu, Q., Zhang, W., Wu, Z., Tian, X., Xiang, J., Li, L., Li, Z., Peng, X., Wei, S., Ma, X., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105444 · Cited by 244
Animal models of chronic liver diseases
Liu, Y., Meyer, C., Xu, C., Weng, H., Hellerbrand, C., ten Dijke, P., & Dooley, S. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00199.2012 · Cited by 233
Metadata
- Authors
- Seth, D., Haber, P. S., Syn, W., Diehl, A. M., & Day, C. P.
- Affiliations
- The University of Sydney (AU)
- University of the Basque Country (ES)
- Duke Medical Center (US)
- Newcastle University (GB)
- Corresponding author
- Seth, Devanshi
- Venue
- Journal of Gastroenterology and Hepatology
- Publisher
- Wiley
- Published
- 2011-06-14
- Volume
- 26
- Issue
- 7
- Pages
- 1089-1105
- ISSN
- 0815-9319 (ISSN-L)
- 1440-1746
- OpenAlex
- W1574483226
- Cited by
- 166
- References
- 219
- Citations by year
- 2025: 10 · 2024: 3 · 2023: 10 · 2022: 6 · 2021: 16 · 2020: 22 · 2019: 4 · 2018: 4 · 2017: 8 · 2016: 12 · 2015: 16 · 2014: 21 · 2013: 17 · 2012: 15
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Gastroenterology and Hepatology (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- National Institutes of Health (5r37aa010154-20)
- National Institute on Alcohol Abuse and Alcoholism (R37 AA-010154)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- alcoholic liver disease, pathogenesis, alcohol metabolism, oxidative stress, endotoxin, cytokines, immune regulation, hepatic stellate cells, hepatic fibrogenesis, myofibroblast transformation, lipogenesis, liver cirrhosis, fibrinolysis, osteopontin, TGF-β/Smad signaling, Hedgehog signaling, nonalcoholic steatohepatitis, genetic polymorphism, epigenomics, animal models, therapeutic target
- MeSH terms
- Alcohol Drinking, Ethanol, Animals, Humans, Liver Diseases, Alcoholic, Risk Factors, Global Health, Prevalence, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
